839 related articles for article (PubMed ID: 29540434)
1. Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon R; Idowu T; Zhanel GG; Schweizer F
Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29540434
[TBL] [Abstract][Full Text] [Related]
2. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids.
Gupta V; Datta P
Indian J Med Res; 2019 Feb; 149(2):97-106. PubMed ID: 31219074
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
Liu Y; Li R; Xiao X; Wang Z
Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli.
Yang X; Ammeter D; Idowu T; Domalaon R; Brizuela M; Okunnu O; Bi L; Guerrero YA; Zhanel GG; Kumar A; Schweizer F
Eur J Med Chem; 2019 Aug; 175():187-200. PubMed ID: 31078866
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
[TBL] [Abstract][Full Text] [Related]
6. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
[TBL] [Abstract][Full Text] [Related]
7. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
[TBL] [Abstract][Full Text] [Related]
8. The development of efflux pump inhibitors to treat Gram-negative infections.
Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
[TBL] [Abstract][Full Text] [Related]
9. Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria.
Yarlagadda V; Manjunath GB; Sarkar P; Akkapeddi P; Paramanandham K; Shome BR; Ravikumar R; Haldar J
ACS Infect Dis; 2016 Feb; 2(2):132-9. PubMed ID: 27624964
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
[TBL] [Abstract][Full Text] [Related]
11. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
[TBL] [Abstract][Full Text] [Related]
12. Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Lyu Y; Yang X; Goswami S; Gorityala BK; Idowu T; Domalaon R; Zhanel GG; Shan A; Schweizer F
J Med Chem; 2017 May; 60(9):3684-3702. PubMed ID: 28409644
[TBL] [Abstract][Full Text] [Related]
13. Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.
Huwaitat R; McCloskey AP; Gilmore BF; Laverty G
Future Microbiol; 2016 Jul; 11():955-72. PubMed ID: 27357521
[TBL] [Abstract][Full Text] [Related]
14. A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria.
Yang X; Goswami S; Gorityala BK; Domalaon R; Lyu Y; Kumar A; Zhanel GG; Schweizer F
J Med Chem; 2017 May; 60(9):3913-3932. PubMed ID: 28399372
[TBL] [Abstract][Full Text] [Related]
15. Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline.
Wang Y; Su J; Zhou Z; Yang J; Liu W; Zhang Y; Zhang P; Guo T; Li G
Microbiol Spectr; 2023 Jun; 11(3):e0470222. PubMed ID: 37070985
[TBL] [Abstract][Full Text] [Related]
16. Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective.
Alibert S; N'gompaza Diarra J; Hernandez J; Stutzmann A; Fouad M; Boyer G; Pagès JM
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):301-309. PubMed ID: 27764576
[TBL] [Abstract][Full Text] [Related]
17. Will new antimicrobials overcome resistance among Gram-negatives?
Bassetti M; Ginocchio F; Mikulska M; Taramasso L; Giacobbe DR
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):909-22. PubMed ID: 21973303
[TBL] [Abstract][Full Text] [Related]
18. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
Nikaido H; Pagès JM
FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
[TBL] [Abstract][Full Text] [Related]
19. Silver enhances antibiotic activity against gram-negative bacteria.
Morones-Ramirez JR; Winkler JA; Spina CS; Collins JJ
Sci Transl Med; 2013 Jun; 5(190):190ra81. PubMed ID: 23785037
[TBL] [Abstract][Full Text] [Related]
20. Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria.
Domalaon R; Brizuela M; Eisner B; Findlay B; Zhanel GG; Schweizer F
Amino Acids; 2019 Mar; 51(3):383-393. PubMed ID: 30392097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
